AKT1 and gastric cancer: Celastrol prevents the proliferation, migration, and invasion of GC cells by downregulating the expression of FOXA1, thereby reducing the transcription of CLDN4, and inhibiting the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway96.